BioCentury
ARTICLE | Top Story

Epizyme soars in trading debut

June 1, 2013 12:19 AM UTC

Epizyme Inc. (NASDAQ:EPZM) jumped $7.99 (53%) to $22.99 on Friday in its first day of trading after the cancer company raised $77.1 million in an IPO on Thursday. The company sold 5.1 million shares at $15, which valued Epizyme at $414.7 million. With Friday's move, the company is now valued at $635.5 million. Epizyme's IPO marks the fifteenth biotech IPO so far in 2013 (see BioCentury, May 27). ...